Pages that link to "Q74514253"
Jump to navigation
Jump to search
The following pages link to Collagen type II C-telopeptide fragments as an index of cartilage degradation (Q74514253):
Displaying 50 items.
- Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application (Q24793640) (← links)
- Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456] (Q24796830) (← links)
- Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173] (Q24816771) (← links)
- The evolving role of biomarkers for osteoarthritis (Q27025115) (← links)
- Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities (Q27687777) (← links)
- Oral Resveratrol Prevents Osteoarthritis Progression in C57BL/6J Mice Fed a High-Fat Diet (Q30384235) (← links)
- Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation? (Q33347582) (← links)
- Schisandrae Fructus ethanol extract ameliorates inflammatory responses and articular cartilage damage in monosodium iodoacetate-induced osteoarthritis in rats (Q33667186) (← links)
- Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort: A randomized double-blind placebo-controlled clinical study (Q33847208) (← links)
- Mitochondrial DNA (mtDNA) haplogroups and serum levels of anti-oxidant enzymes in patients with osteoarthritis (Q34080402) (← links)
- Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis (Q34122276) (← links)
- Predicting outcomes in early rheumatoid arthritis (Q34637296) (← links)
- Characterization of an Ex vivo Femoral Head Model Assessed by Markers of Bone and Cartilage Turnover (Q34991612) (← links)
- Cytokines as biochemical markers for knee osteoarthritis. (Q35003515) (← links)
- Relationship between CTX-II and patient characteristics, patient-reported outcome, muscle strength, and rehabilitation in patients with a focal cartilage lesion of the knee: a prospective exploratory cohort study of 48 patients (Q35128860) (← links)
- Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency (Q35355366) (← links)
- Whole blood lead levels are associated with biomarkers of joint tissue metabolism in African American and white men and women: the Johnston County Osteoarthritis Project. (Q35535695) (← links)
- Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products (Q35551655) (← links)
- Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis (Q35552085) (← links)
- Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index (Q35552529) (← links)
- Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis (Q35554303) (← links)
- Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis (Q35578072) (← links)
- The effects of a calcium-rich pre-exercise meal on biomarkers of calcium homeostasis in competitive female cyclists: a randomised crossover trial (Q35601894) (← links)
- Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis (Q35620328) (← links)
- Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis (Q35636670) (← links)
- Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study (Q35636890) (← links)
- Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort (Q35636920) (← links)
- Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. (Q35637421) (← links)
- Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis (Q35637511) (← links)
- Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis (Q35638463) (← links)
- 6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents (Q35683586) (← links)
- Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis (Q35769088) (← links)
- Radiological and biochemical effects (CTX-II, MMP-3, 8, and 13) of low-level laser therapy (LLLT) in chronic osteoarthritis in Al-Kharj, Saudi Arabia. (Q36212495) (← links)
- Validation of new biomarkers in systemic autoimmune diseases (Q36231859) (← links)
- Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage (Q36245974) (← links)
- Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study (Q36401945) (← links)
- Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study (Q36493865) (← links)
- Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis (Q36598469) (← links)
- Monitoring cartilage turnover (Q36793231) (← links)
- Biological markers in osteoarthritis (Q36835538) (← links)
- Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis (Q37040977) (← links)
- Serum protein signatures detect early radiographic osteoarthritis (Q37154116) (← links)
- Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study (Q37204153) (← links)
- The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover (Q37207066) (← links)
- Collagen biomarkers for arthritis applications. (Q37277952) (← links)
- Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers (Q37350908) (← links)
- Whither osteoarthritis biomarkers? (Q37378390) (← links)
- Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. (Q37457066) (← links)
- Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients? (Q37679653) (← links)
- Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis (Q37757754) (← links)